Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study-Reference-Cited by-同舟云学术

Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study

Published:2022-07 Issue: Volume:169 Page:146-155
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Leyvraz Serge^ORCID,Konietschke Frank^ORCID,Peuker Caroline^ORCID,Schütte Moritz,Kessler Thomas^ORCID,Ochsenreither Sebastian,Ditzhaus Marc^ORCID,Sprünken Erin D.,Dörpholz Gina,Lamping Mario,Rieke Damian T.^ORCID,Klinghammer Konrad^ORCID,Burock Susen,Ulrich Claas^ORCID,Poch Gabriela^ORCID,Schäfer Reinhold,Klauschen Frederick^ORCID,Joussen Antonia,Yaspo Marie-Laure,Keilholz Ulrich

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. The Zimmerman-McLean-Foster hypothesis: 25 years later;Singh;Br J Ophthalmol,2004

2. Molecular pathology of uveal melanoma;Coupland;Eye,2013

3. Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma;Onken;Ophthalmology,2012

4. Dual immunological checkpoint blockade for uveal melanoma;Khan;J Clin Oncol,2021

5. Overall survival benefit with tebentafusp in metastatic uveal melanoma;Nathan;N Engl J Med,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity and molecular landscape of melanoma: implications for targeted therapy;Molecular Biomedicine;2024-05-10

2. Stereotactic radiotherapy for uveal melanoma: A case report;Molecular and Clinical Oncology;2024-01-30

3. News from the OOG Meeting in April 2023 in Berlin;Klinische Monatsblätter für Augenheilkunde;2023-07

4. Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs;Cancers;2023-01-20

5. Treatment with anti-HER2 chimeric antigen receptor tumor-infiltrating lymphocytes (CAR-TILs) is safe and associated with antitumor efficacy in mice and companion dogs;2022-09-13